We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Scientists Identify Synthetic, Macrocyclic, Orally Bioavailable Cyclophilin Inhibitors with Potent HCV Activity

Product News   Sep 21, 2018

 
Scientists Identify Synthetic, Macrocyclic, Orally Bioavailable Cyclophilin Inhibitors with Potent HCV Activity
FURTHER INFORMATION
 
 
 

Related Product News

Cytel To Hold Complex Innovative Trial Design Symposium

Product News

The Complex Innovative Trial Design Symposium will take place November 6–7 at Alexion’s headquarters in Boston, Massachusetts, bringing together industry-leading experts to discuss innovative solutions to pressing challenges including rare disease clinical trials.

READ MORE

Enterprise Therapeutics Awarded Up to $7M From Cystic Fibrosis Foundation

Product News

Enterprise Therapeutics has been awarded up to $7m towards the development of novel therapeutics for respiratory diseases.

READ MORE

Making Cryo-solutions Sustainable

Product News

Eppendorf has re-designed its ultra-low temperature freezer to be more sustainable.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE